✦ LIBER ✦

A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103)

✍ Scribed by Tianhong Li, Mengye Guo, William J. Gradishar, Joseph A. Sparano, Edith A. Perez, Molin Wang, George W. Sledge

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Trial of Gemcitabine in Patie

✍ Shanu Modi; Violante E. Currie; Andrew D. Seidman; Ariadne M. Bach; Katherine S. 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 868 KB

An all-oral combination of metronomic cy

✍ Zhonghua Wang; Jingsong Lu; Shiangjiin Leaw; Xiaonan Hong; Jialei Wang; Zhimin S 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 223 KB

A Phase I Study of an All-Oral Combinati

✍ Pirkko-Liisa Kellokumpu-Lehtinen; Kaisa Sunela; Ilari Lehtinen; Heikki Joensuu; 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 125 KB

A Phase II trial of the combination of v

✍ George Orphanos; Athanasios Alexopoulos; Savvoula Malliou; George Ioannidis; Ale 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 312 KB

Phase II Study of Pemetrexed in Patients

✍ Joyce A. O'Shaughnessy; Romnee S. Clark; Joanne L. Blum; Robert G. Mennel; David 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 518 KB

Phase II Trial of Capecitabine and Weekl

✍ Joanne L. Blum; E. Claire Dees; Svetislava J. Vukelja; Mammo Amare; David P. Gil 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 111 KB